Year |
Citation |
Score |
2023 |
Yin W, Egawa N, Zheng K, Griffin H, Tian P, Aiyenuro A, Bornstein J, Doorbar J. HPV E6 inhibits E6AP to regulate epithelial homeostasis by modulating keratinocyte differentiation commitment and YAP1 activation. Plos Pathogens. 19: e1011464. PMID 37379354 DOI: 10.1371/journal.ppat.1011464 |
0.312 |
|
2021 |
Khelil M, Griffin H, Bleeker MCG, Steenbergen RDM, Zheng K, Saunders-Wood T, Samuels S, Rotman J, Vos W, van den Akker BE, de Menezes RX, Kenter GG, Doorbar J, Jordanova ES. Delta-like ligand-Notch1 signalling is selectively modulated by HPV16 E6 to promote squamous cell proliferation and correlates with cervical cancer prognosis. Cancer Research. PMID 33500246 DOI: 10.1158/0008-5472.CAN-20-1996 |
0.325 |
|
2020 |
Shiraz A, Crawford R, Egawa N, Griffin H, Doorbar J. The Early Detection of Cervical Cancer. The current and changing landscape of cervical disease detection. Cytopathology : Official Journal of the British Society For Clinical Cytology. PMID 32301535 DOI: 10.1111/cyt.12835 |
0.309 |
|
2019 |
Griffin H, Singh Mudhar H, Rundle P, Shiraz A, Mahmood R, Egawa N, Quint W, Rennie IG, Doorbar J. Human papillomavirus type 16 causes a defined subset of conjunctival in situ squamous cell carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31485010 DOI: 10.1038/s41379-019-0350-5 |
0.326 |
|
2019 |
Doorbar J, Griffin H. Refining our understanding of cervical neoplasia and its cellular origins. Papillomavirus Research (Amsterdam, Netherlands). 7: 176-179. PMID 30974183 DOI: 10.1016/j.pvr.2019.04.005 |
0.303 |
|
2019 |
Hammer A, de Koning MN, Blaakaer J, Steiniche T, Doorbar J, Griffin H, Mejlgaard E, Svanholm H, Quint WG, Gravitt PE. Whole tissue cervical mapping of HPV infection: molecular evidence for focal latent HPV infection in humans. Papillomavirus Research (Amsterdam, Netherlands). PMID 30772498 DOI: 10.1016/j.pvr.2019.02.004 |
0.316 |
|
2018 |
Stevenson A, Kavanagh K, Pan J, Stevenson L, Griffin H, Doorbar J, Scott E, Deeny M, Cuschieri K, Graham SV. Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 108: 19-25. PMID 30218891 DOI: 10.1016/j.jcv.2018.08.011 |
0.313 |
|
2015 |
van Baars R, Griffin H, Wu Z, Soneji YJ, van de Sandt MM, Arora R, van der Marel J, Ter Harmsel B, Jach R, Okon K, Huras H, Jenkins D, Quint WG, Doorbar J. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a. The American Journal of Surgical Pathology. 39: 1518-28. PMID 26379150 DOI: 10.1097/PAS.0000000000000498 |
0.313 |
|
2015 |
Griffin H, Soneji Y, Van Baars R, Arora R, Jenkins D, van de Sandt M, Wu Z, Quint W, Jach R, Okon K, Huras H, Singer A, Doorbar J. Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 977-93. PMID 25953390 DOI: 10.1038/modpathol.2015.52 |
0.317 |
|
2015 |
Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Reviews in Medical Virology. 25: 2-23. PMID 25752814 DOI: 10.1002/rmv.1822 |
0.342 |
|
2012 |
Griffin H, Wu Z, Marnane R, Dewar V, Molijn A, Quint W, Van Hoof C, Struyf F, Colau B, Jenkins D, Doorbar J. E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease. Plos One. 7: e49974. PMID 23226504 DOI: 10.1371/journal.pone.0049974 |
0.341 |
|
2012 |
Isaacson Wechsler E, Wang Q, Roberts I, Pagliarulo E, Jackson D, Untersperger C, Coleman N, Griffin H, Doorbar J. Reconstruction of human papillomavirus type 16-mediated early-stage neoplasia implicates E6/E7 deregulation and the loss of contact inhibition in neoplastic progression. Journal of Virology. 86: 6358-64. PMID 22457518 DOI: 10.1128/Jvi.07069-11 |
0.322 |
|
2007 |
Doorbar J, Griffin H. Intrabody strategies for the treatment of human papillomavirus-associated disease. Expert Opinion On Biological Therapy. 7: 677-89. PMID 17477805 DOI: 10.1517/14712598.7.5.677 |
0.32 |
|
2006 |
Griffin H, Elston R, Jackson D, Ansell K, Coleman M, Winter G, Doorbar J. Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting. Journal of Molecular Biology. 355: 360-78. PMID 16324714 DOI: 10.1016/j.jmb.2005.10.077 |
0.314 |
|
2003 |
Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T, El-Sherif A, Morris L, Seth R, Hibma M, Jenkins D, Lambert P, Coleman N, Doorbar J. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. Journal of Virology. 77: 10186-201. PMID 12970404 DOI: 10.1128/Jvi.77.19.10186-10201.2003 |
0.327 |
|
Show low-probability matches. |